Recent Advances in the Prevention and Screening of Preeclampsia by Balázs Mészáros, Zoltán Kukor, Sándor Valent

“…The purpose of this review is to summarize the knowledge of the possible novel prophylactic therapies and screening methods for preeclampsia, thereby providing valuable insights for healthcare professionals and researchers. …”
Get full text

Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer by Alejandra Vargas, Priyata Dutta, Eileen S. Carpenter, Jorge D. Machicado

“…However, only a dismal proportion of patients are eligible for surgery. Therefore, novel treatment approaches to treat pancreatic cancer and precancerous pancreatic cysts are needed. …”
Get full text

The Antibacterial and Remineralizing Effects of Biomaterials Combined with DMAHDM Nanocomposite: A Systematic Review by Alison Clarin, Daphne Ho, Jana Soong, Cheryl Looi, Deepak Samuel Ipe, Santosh Kumar Tadakamadla

“…Researchers have developed novel nanocomposites that incorporate additional biomaterials with dimethylaminohexadecyl methacrylate (DMAHDM) in order to reduce secondary caries. …”
Get full text

An Improved Fuzzy C-Means Algorithm for the Implementation of Demand Side Management Measures by Ioannis Panapakidis, Nikolaos Asimopoulos, Athanasios Dagoumas, Georgios C. Christoforidis

“…Additionally, this paper proposes a novel Demand Side Management (DSM) strategy for load management of consumers that are eligible for the implementation of Real-Time Pricing (RTP) schemes. …”
Get full text

“Particle therapy - future for the Baltic states?” – synthesis of the expert workshop report by Paļskis, K, Korobeinikova, E, Bogorada-Saukuma, D, Camarda, AM, Taylor, R, Benedetto, E, Mamis, E, Radziņa, M, Ērglis, A, Adliene, D, Dosanjh, M, Vretenar, M, Torims, T

“…An initiative since 2021 has been started by CERN Baltic Group on a novel particle therapy center development in the region in partnership with CERN NIMMS collaboration. …”

Overcoming Depression with 5-HT_2A Receptor Ligands by Agata Zięba, Piotr Stępnicki, Dariusz Matosiuk, Agnieszka A. Kaczor

“…Thus, there is a need for developing novel, potent, and safer agents. Recent medicinal chemistry findings on the structure and function of the serotonin 2A (5-HT_2A) receptor facilitated design and discovery of novel compounds with antidepressant action. …”
Get full text

Obinutuzumab, High-Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients with Richter’s Syndrome by Benjamin M. Heyman, Michael Y. Choi, Thomas J. Kipps

“…Significant efforts have focused on the development of novel treatments with reduced toxicity. We describe our experience using the novel combination of obinutuzumab, high-dose methylprednisolone (HDMP) and lenalidomide (len) in patients with RS. …”
Get full text

B-Lymphoid Blast Phase–Chronic Myeloid Leukemia: Current Therapeutics by Binoy Yohannan, Binsah George

“…The primary objective of initial treatment in BC is to achieve a second chronic phase (CP) and to proceed to an allogeneic stem cell transplantation (SCT) in eligible patients. The clinical outcome of patients with CML BC remains unsatisfactory, even with highly potent TKIs, as remissions are short lived and there is an unmet need for novel therapies. …”
Get full text

Acute Myeloid Leukemia Evolving from Myeloproliferative Neoplasms: Many Sides of a Challenging Disease by Francesco Mannelli

“…At transformation, the crucial target of treatment should be the allocation to allogeneic transplant for eligible patients. With this in mind, novel combination treatments may provide useful bridging strategies, beyond potentially improving outcomes for patients who are not candidates for intensive approaches.…”
Get full text

Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a populatio... by Rujipat Wasitthankasem, Preeyaporn Vichaiwattana, Nipaporn Siripon, Nawarat Posuwan, Chompoonut Auphimai, Sirapa Klinfueng, Napha Thanetkongtong, Viboonsak Vuthitanachot, Supapith Saiyatha, Chaiwat Thongmai, Saowakon Sochoo, Natnada Pongsuwan, Kittiyod Poovorawan, Pisit Tangkijvanich, Yong Poovorawan

“…The number of patients eligible for Universal Health Coverage (UC) scheme and the approximately required expenditure on interferon (IFN)-based treatment were estimated. …”
Get full text

Thromboembolic events in hospitalised patients with COVID-19: ecological assessment with a scoping review by Tomoko Fujii, Saori Kurata, Naoki Miyayama, Kenta Ogawa, Kaede Watanabe, Kengo Asano

“…Objectives Thrombosis is a common complication of the novel COVID-19. Pre-COVID-19 studies reported racial differences in the risk of developing thrombosis. …”
Get full text

Association between omentin and obstructive sleep apnea: A meta‐analysis by Ningning She, Na Liu, Xiaoyong Ren, Haiqin Liu

“…Result A total of eight eligible studies with 23 databases involving 914 participants were included in this meta‐analysis. …”
Get full text

Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database by Roberto Carmagnani Pestana, César Serrano, César Serrano

“…BackgroundThe development of novel therapies for patients with sarcoma is challenging due to the rarity and diversity of these mesenchymal neoplasms. …”
Get full text

Augmenting family based treatment with emotion coaching for adolescents with anorexia nervosa and atypical anorexia nervosa: Trial design and methodological report by Claire M. Aarnio-Peterson, Constance A. Mara, Avani C. Modi, Abigail Matthews, Daniel Le Grange, Anne Shaffer

“…Thus, we proceeded with the small randomized controlled trial (RCT). Eligible families were randomized to either 10 weeks of FBT + EC parent group treatment or the 10- week parent support group (control condition). …”
Get full text

How Efficient Is the Implementation of Structural Funds Committed to Enhancing ICT Adoption in SMEs? by Carla Henriques, Clara Viseu

“…Without the removal of the environmental factors, the “number of operations supported” is the indicator that requires more attention from management authorities (MAs), whereas with their removal one-third of the OPs need to further reduce the “eligible costs decided” and improve “eligible spending”. …”
Get full text

Alternative physical treatments for deep venous thrombosis prophylaxis in surgical patients: a systematic review by Berner, JE, Geoghegan, L, Kyriazidis, I, Nanchahal, J, Jain, A

“…Introduction Venous thromboembolism (VTE) represents a major cause of morbidity and mortality. A variety of novel physical therapies have been proposed for patients in whom standard prophylaxis, including early mobilisation, is contraindicated. …”

A potential biomarker of cognitive impairment: The olfactory dysfunction and its genes expression by Jiayi Song, Jiahui Xu, Wei Yuan, Ruixue Li, Hui Guo, Hanshu Gao, Cuiying Gu, Wenjing Feng, Yanan Ma, Haiqiang Guo, Zhaoqing Sun, Liqiang Zheng

“…Interpretation These findings proved novel insight into identifying olfactory dysfunction as potential biomarker for diagnosis of cognitive impairment.…”
Get full text

Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis by Giorgio Frega, Fernando P. Cossio, Jesus M. Banales, Vincenzo Cardinale, Rocio I. R. Macias, Chiara Braconi, Angela Lamarca

“…Methods: Prisma guidelines were followed for this systematic review and meta-analysis. Eligible studies were searched on PubMed. Studies published between 2017 and 2022, reporting data on PD-1/PD-L1 expression and other immune-related biomarkers in patients with BTC, were considered eligible. …”
Get full text

Optimization and privacy protection of microgrid power trading system based on attribute encryption technology by Kangqian Huang, Xin Hu, Rui Zhou, Dejun Xiang

“…By embedding advanced cryptographic techniques into the operational substrate of microgrids, we introduce a novel approach to dramatically enhance the efficiency of energy distribution, while guaranteeing the privacy protection and integrity of participant data. …”
Get full text

Immunotherapy in Acute Leukemias: Past Success Paves the Way for Future Progress by Adel Chergui, John L. Reagan

“…Pre-clinical data and clinical trials have shown promising results for novel immunotherapies in acute leukemia, and multiple ongoing trials are investigating these novel approaches. …”
Get full text